Emergency use authorization for nitazoxanide as a potential treatment for COVID-19 is requested from the FDA in the US, signaling ongoing efforts to repurpose existing drugs for combating the pandemic and expanding therapeutic options for affected individuals.
January 2022
Increased screen time at night during COVID-19 lockdown negatively affects sleep quality, emphasizing the importance of establishing healthy screen habits and promoting sleep hygiene practices to mitigate mental health consequences of prolonged digital exposure.
January 2022
Breast milk from vaccinated mothers shows strong secretion of SARS-CoV-2-specific IgA and IgG antibodies for up to 6 weeks post-vaccination, supporting the safety and efficacy of COVID-19 vaccination in breastfeeding women and passive immunity transfer to infants.
December 2021
Review provides insights into the most frequent thyroid hormone alterations observed in patients with COVID-19, highlighting the complex interplay between viral infection and endocrine dysfunction in affected individuals.
December 2021
Patients with obesity have a 30% higher risk of hospital admission for long-term complications of COVID-19, highlighting the need for targeted interventions and public health initiatives to mitigate disparities and improve outcomes in vulnerable populations.
December 2021
Individuals who trust television and social media as reliable sources of COVID-19 news may exhibit lower levels of information comprehension and awareness, highlighting the need for targeted health communication strategies to address knowledge gaps and misinformation dissemination.
December 2021